6CYM
Reversible Covalent Direct Thrombin Inhibitors
Summary for 6CYM
Entry DOI | 10.2210/pdb6cym/pdb |
Descriptor | Prothrombin, 2-methoxybenzoic acid, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... (6 entities in total) |
Functional Keywords | hydrolase, blood coagulation, plasma, calcium-binding, glycoprotein, serine protease, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 4 |
Total formula weight | 66739.35 |
Authors | Sivaraja, M.,Williams, D.C. (deposition date: 2018-04-06, release date: 2018-05-09, Last modification date: 2020-07-29) |
Primary citation | Sivaraja, M.,Pozzi, N.,Rienzo, M.,Lin, K.,Shiau, T.P.,Clemens, D.M.,Igoudin, L.,Zalicki, P.,Chang, S.S.,Estiarte, M.A.,Short, K.M.,Williams, D.C.,Datta, A.,Di Cera, E.,Kita, D.B. Reversible covalent direct thrombin inhibitors. PLoS ONE, 13:e0201377-e0201377, 2018 Cited by PubMed: 30071045DOI: 10.1371/journal.pone.0201377 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.9 Å) |
Structure validation
Download full validation report